Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects.
Oncotarget
; 2(12): 1155-64, 2011 Dec.
Article
in En
| MEDLINE
| ID: mdl-22201704
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interferon-alpha
/
Antimony Sodium Gluconate
/
Drug Therapy, Combination
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Oncotarget
Year:
2011
Document type:
Article
Affiliation country:
United States